Gelesis Holdings, Inc. (GLSHQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 | 62.26 Million USD | -6.05% |
| 2021 | 66.26 Million USD | 0.0% |
| 2020 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q2 | 61.87 Million USD | 1.66% |
| 2023 Q1 | 60.86 Million USD | -2.24% |
| 2022 FY | 62.26 Million USD | -6.05% |
| 2022 Q4 | 62.26 Million USD | 6.45% |
| 2022 Q1 | 37.88 Million USD | -42.84% |
| 2022 Q2 | 34.96 Million USD | -7.7% |
| 2022 Q3 | 58.49 Million USD | 67.29% |
| 2021 Q1 | - USD | 0.0% |
| 2021 FY | 66.26 Million USD | 0.0% |
| 2021 Q4 | 66.26 Million USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | -51.113% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -1410.52% |
| SQZ Biotechnologies Company | 27.47 Million USD | -126.65% |
| Evofem Biosciences, Inc. | 43.37 Million USD | -43.552% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | -109.167% |
| Mesoblast Limited | 118.7 Million USD | 47.546% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -6465.95% |
| Genus plc | 233.1 Million USD | 73.289% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -2024.736% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -4534.098% |
| Marizyme, Inc. | 18.71 Million USD | -232.646% |
| ContraFect Corporation | 2.88 Million USD | -2061.159% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -8201.733% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -45854.962% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -4204.929% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -2576.879% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -1000.373% |
| MultiCell Technologies, Inc. | 202.58 USD | -30734918.264% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | -8.304% |
| EV Biologics, Inc. | 1.49 Million USD | -4065.443% |
| Q BioMed Inc. | 4.1 Million USD | -1414.922% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | -88.1% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -9781.808% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -4968.787% |
| Biomind Labs Inc. | 735.54 Thousand USD | -8364.914% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 171.54 Million USD | 63.705% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -379.057% |
| Skye Bioscience, Inc. | 4.61 Million USD | -1249.066% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -6911.094% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -43896.523% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -960.502% |
| IMV Inc. | 28.88 Million USD | -115.563% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -241989.506% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -2656.975% |
| GB Sciences, Inc. | 1.75 Million USD | -3439.064% |
| Alpha Cognition Inc. | 1.22 Million USD | -5001.969% |
| HST Global, Inc. | 98.31 Thousand USD | -63227.536% |
| CSL Limited | 12.18 Billion USD | 99.489% |
| Halberd Corporation | 150 Thousand USD | -41408.667% |
| Enzolytics Inc. | 996.33 Thousand USD | -6149.185% |
| Resverlogix Corp. | 6.49 Million USD | -859.22% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 477.5 Thousand USD | -12939.372% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -24260.309% |
| argenx SE | 20 Million USD | -211.315% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | -36.662% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -2198.628% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -608829.095% |
| Genscript Biotech Corporation | 417.73 Million USD | 85.095% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -30935.909% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -2496.754% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -27054.576% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | 7.953% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -1957.471% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -17209.221% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | -206.292% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -41784.51% |
| BioStem Technologies, Inc. | 4.71 Million USD | -1221.534% |
| ONE Bio Corp. | 19.71 Million USD | -215.815% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -24787.082% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -24933.371% |
| Agentix Corp. | 50 Thousand USD | -124426.0% |
| LadRx Corporation | 33.6 Thousand USD | -185173.463% |
| Cell Source, Inc. | 9.25 Million USD | -572.81% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -8133.625% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -8133.625% |
| NovAccess Global Inc. | 2.19 Million USD | -2730.291% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -780.315% |
| Itoco Inc. | 228.37 Thousand USD | -27163.253% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -29412.027% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -1149.508% |
| Kadimastem Ltd | 891.22 Thousand USD | -6886.219% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -15394.128% |
| CytoDyn Inc. | 30.07 Million USD | -107.019% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | 484.28 Thousand USD | -12756.712% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -17596.044% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -696.206% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -50726.939% |
| Rebus Holdings, Inc. | 310 Thousand USD | -19984.839% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -1214.874% |
| International Stem Cell Corporation | 4.17 Million USD | -1390.258% |
| Bioxytran, Inc. | 1.92 Million USD | -3134.442% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -99659.665% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -2754.922% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -648.713% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -625.253% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -3902.818% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -23132.463% |
| Neutra Corp. | 54.15 Thousand USD | -114869.717% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -3302.35% |
| PureTech Health plc | 25.51 Million USD | -144.054% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -4985.907% |
| IXICO plc | 472.02 Thousand USD | -13090.671% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -301.671% |
| CSL Limited | 12.18 Billion USD | 99.489% |
| Cellectis S.A. | 92.77 Million USD | 32.889% |